Pharvaris N.V.
(PHVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,104 | 170,512 | 199,153 | 214,312 | 218,576 |
| Receivables | 423 | 403 | 407 | 353 | 751 |
| Income taxes - deferred | N/A | N/A | 241 | 106 | 153 |
| Other current assets | 12,403 | 4,875 | 4,262 | 4,869 | 5,838 |
| TOTAL | $157,929 | $175,790 | $204,063 | $219,641 | $225,318 |
| Non-Current Assets | |||||
| PPE Net | 214 | 204 | 183 | 151 | 142 |
| Other Non-Current Assets | 506 | 730 | 197 | 224 | 250 |
| TOTAL | $720 | $934 | $381 | $375 | $392 |
| Total Assets | $158,649 | $176,724 | $204,444 | $220,016 | $225,710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,620 | 7,043 | 7,147 | 4,437 | 3,766 |
| Accrued Expenses | 10,609 | 11,475 | 10,204 | 9,558 | 7,331 |
| TOTAL | $19,852 | $19,201 | $17,852 | $17,099 | $11,357 |
| Non-Current Liabilities | |||||
| TOTAL | $170 | $263 | $87 | $109 | $138 |
| Total Liabilities | $20,022 | $19,464 | $17,939 | $17,207 | $11,494 |
| Shareholders' Equity | |||||
| Common Shares | 4,358 | 4,276 | 4,084 | 4,312 | 4,464 |
| Retained earnings | -200,568 | -172,989 | -125,813 | -123,700 | -116,255 |
| Other shareholders' equity | 24,139 | 21,296 | 17,696 | 15,600 | 13,193 |
| TOTAL | $138,627 | $157,259 | $186,505 | $202,809 | $214,217 |
| Total Liabilities And Equity | $158,649 | $176,724 | $204,444 | $220,016 | $225,711 |